The global pharmacogenomics (PGX) market size was valued at USD 6.13 billion in 2024 and is projected to grow from USD 6.69 billion in 2025 to USD 11.17 billion by 2033, exhibiting a CAGR of 6.6% during the forecast period (2025-2033).
This report provides an in-depth analysis of the Pharmacogenomics (PGX) Market at global, regional, and country levels. It examines market size, regional performance, and competitive strategies of leading companies, supported by a SWOT analysis. The study uses a robust methodology combining primary and secondary research with validated forecasting techniques to deliver accurate and reliable market insights.
The main goal of this report is to offer actionable insights into Pharmacogenomics (PGX) Market trends, growth drivers, and key factors affecting industry performance. It covers market structure, segmentation, and projected market value, while identifying growth opportunities, challenges, and trends shaped by technology, regulations, cost efficiency, and changing consumer demand.
Download Sample Report PDF
https://straitsresearch.com/report/pharmacogenomics-market/request-sample
The report provides detailed analysis across major regions, including North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. Each region is evaluated for Pharmacogenomics (PGX) Market size, growth trends, trade patterns, and overall industry maturity. This segmentation helps identify competitive strengths and untapped growth potential in each region.
By Type
Products
Genotyping Kits
Sequencing Instruments
PCR Reagents and Consumables
Sample Preparation Kits
Others
Services
Genetic Testing Services
Pharmacogenomic Consulting
Others
Software
Bioinformatics Software
Clinical Decision Support System
Laboratory Information Management System
EHR Integration Software
Others
By Technology
Next-Generation Sequencing
Polymerase Chain Reaction
Mass Spectrometry
Microarray
Others
By Application
Cardiovascular disease
Infectious diseases
Oncology
Neurological diseases
Pain Management and Trauma
Others
By End-User
Hospitals
Clinical Laboratories
Pharmaceutical Companies
Academic Research Institutions
Others
QIAGEN
Illumina, Inc.
Agilent Technologies, Inc.
Foundation Medicine, Inc.
Thermo Fisher Scientific Inc.
Admera Health
Myriad Genetics, Inc.
Beckman Coulter, Inc.
OneOme
Genomind
Coriell Life Sciences
PGxAI
Tempus
DEEP GENOMICS
Helix, Inc.
Oxford Nanopore Technologies plc.
Download Sample Report PDF
https://straitsresearch.com/report/pharmacogenomics-market/request-sample
What is the market overview of the Pharmacogenomics (PGX) Market?
What was the market size in 2024?
What is the projected CAGR during the forecast period?
Which factors are driving market growth?
How is the market segmented?
What strategies are adopted by leading companies?
Which trends and applications are shaping industry development?
Who are the top participants in the market?
What are the key capabilities and product offerings of leading companies?
Straits Research has over 10 years of experience providing data-driven insights to more than 2,025 organizations worldwide, from startups to global enterprises. Our syndicated research reports cover high-impact industries such as chemicals, food and beverages, healthcare, automotive, technology, aerospace, and defense. We also offer customized research solutions to support strategic decision-making and business growth.